Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(Nasdaq: MIRM) today announced that on 10, 2025, the Compensation Committee of Mirum’s Board of Directors granted inducement ...
Daily4d
Upadacitinib Shows Long-Term Success in the Treatment of Atopic Dermatitis, finds study
A recent study published in the Dermatology and Therapy journal confirmed the effectiveness and safety of upadacitinib, a ...